Mozifor (Plerixafor Vials) 24mg/1.2ml (20mg/ml)

Mozifor (Plerixafor) is an injectable medication used to mobilize stem cells in the bloodstream for collection prior to stem cell transplantation. It supports blood cell production in patients preparing for certain cancer treatments. Store at ambient temperature.

Strength

24mg/1.2ml (20mg/ml)

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Aspiro Pharma Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mozifor is primarily used to help increase the number of stem cells in the blood so they can be collected and used for stem cell transplantation. This process is often part of treatment for certain cancers like lymphoma or multiple myeloma. It works by blocking a protein that traps stem cells in the bone marrow, allowing them to move into the bloodstream.

Side Effects

Mozifor helps the body release stem cells into the bloodstream, making them easier to collect for medical procedures. Patients may experience mild effects such as nausea, diarrhea, or headache during treatment. These effects are generally temporary and related to the body’s response to stem cell mobilization.

Precautions & Warnings

Keep Mozifor vials at room temperature and protect them from light. Do not freeze or expose to extreme heat. Always handle injections with care and follow proper disposal methods for used needles and vials. Consult a healthcare provider if you experience persistent discomfort after administration.

Avoid Interactions

Mozifor may interact with other medications that affect blood cell counts or bone marrow function. Avoid combining it with drugs known to lower white blood cell counts, such as certain chemotherapy agents. Always inform your doctor about all medications you are taking before starting Mozifor.

References

Frequently Asked Questions

Mozifor is used to help collect stem cells from the blood for stem cell transplantation in patients with certain cancers.

Mozifor is given as an injection under the skin, typically by a healthcare professional before stem cell collection.

Common side effects may include nausea, diarrhea, headache, or dizziness. These effects are usually temporary.

Yes, Mozifor vials should be stored at ambient temperature and protected from light.

Yes, Mozifor is a prescription medication and should only be used under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.